Skip to main content

VAXARRAY®

Designed To Reduce Your Analytical Development Bottlenecks. 

With fast evolving diseases and pandemics, the challenge of analytical development for the vaccine industry has never been so great. The need to provide patients with effective and safe vaccines in reduced time frames is increasing. Your vaccine candidates’ development require optimization by reducing your analytical bottlenecks. 

With a partner-first approach to the pharmaceutical industry, bioMérieux joins forces with U.S. biotechnology Company InDevR, manufacturer of the VaxArray® technology, to provide the vaccine industry with a new simplified and rapid analytical solution.

VaxArray® is a multiplexed immunoassay technology for vaccine characterization. It allows manufacturers to have clearer insights into the evolution, manufacturing and release of their vaccine products.   

Product Overview

VaxArray® is a multiplexed immunoassay technology for protein and mRNA-based vaccines potency and characterization. It allows manufacturers to have clearer insights into the evolution, manufacture and release of their vaccine products. 

VaxArray® offers off-shelf kits for Influenza and Pneumococcal applications. 

Working on other applications? Contact us and meet with our expert services. We can develop customs kits, specifically tailored for your vaccine. We also provide testing services for fast and effective answers. 

bioMérieux is the exclusive distributor of VaxArray® in Europe. 

 

Please accept targeting cookies to allow Youtube video

 

 

 

Technology

The VaxArray® technology relies on multiplexed immunoassays with fluorescent detection labels. VaxArray® is compatible with different therapeutic modalities including egg- and cell-based vaccine production methods as well as mRNA in vivo expression.

 

Benefits

  •      Increased analytical development efficiency
  •      Analytical development cost optimization

 

 

Features

  • Early available ready-to-use kits for every flu campaign
  • Fast time to result
  • Easier to use than in-house methods
  • Low volume sample required for testing
  • Highly multiplexed for broad valence capture
  • Compatible from crude to purified samples
  • High sensitivity
  • Software is 21 CFR Part 11 compatible

 

Reagents

A variety of off-shelf kits is available for influenza and pneumococcal applications. 

For other applications, refer to our Expert Services

Please note that the detection labels are to be purchased separately from the kits. 

The multiplexing ability of VaxArray® relies on the precise geographical printing of the capture molecule onto the slide. 

 

 

Influenza multivalent kits

  • OmniFlu HA Multivalent Assay
  • Influenza HEK293 HA Multivalent
  • VaxArray® Influenza Seasonal HA Multivalent Assay V3.0 and V4.0
  • Influenz Pandemic HA Multivalent Assay V1.1
  • VaxArray® Influenza Seasonal NA Multivalent Assay V2.0
  • VaxArray® Influenza NP Multivalent Assay

 

Influenza monovalent kits

  • Influenza A/H1 Assay
  • Influenza A/H3 Assay V2.0
  • Influenza A/H3 Assay V3.0
  • Influenza B/Yamagata HA Assay
  • Influenza B/Victoria HA Assay

 

Pneumococcal multivalent kit 

  • Pneumococcal multivalent assay

Support and Services

  • Testing services 
  • Custom services 
  • On-demand scientific support
  • Installation, operation and performance qualification support

Resources - Brochures

InDevR - OmniFlu HA (Brochure)

Download the Brochure

Filename
InDevR_Flyer_2-OmniFlu_HA-DIGITAL.pdf
Size
348 KB
Format
application/pdf

InDevR - Expert Services (Brochure)

Download the Document

Filename
InDevR_Flyer_3-Expert_Services-DIGITAL.pdf
Size
419 KB
Format
application/pdf

InDevR - mRNA Applications (Brochure)

Download the Document

Filename
InDevR_Flyer_4-mRNA-draft6.pdf
Size
525 KB
Format
application/pdf

InDevR - VaxArray (Brochure)

Download the Document

Filename
InDevR_Flyer_5-VaxArray-DIGITAL.pdf
Size
466 KB
Format
application/pdf

 

 

Webinar

Next Generation MRNA CQA Analytics

Whitepapers

VaxArray for Rapid CQA Identity and Quantity for Multivalent mRNA Drug Product

Download the Document

Filename
2022 VaxArray for Rapid CQA Identity and Quantity for Multivalent mRNA Drug Product (1).pdf
Size
16 MB
Format
application/pdf

VaxArray 30-Minute Multiplexed Assay for Pneumococcal Vaccine Antigen Characterization

Download the Document

Filename
2022 VaxArray 30-Minute Multiplexed Assay for Pneumococcal Vaccine Antigen Characterization.pdf
Size
2 MB
Format
application/pdf

2019 VaxArray Why Quantitative Assessment of NA is as Critical as HA

Download the Document

Filename
2019 VaxArray Why Quantitative Assessment of NA is as Critical as HA.pdf
Size
1017 KB
Format
application/pdf

VaxArray Pandemic Influenza Potency Test Assessment and Comparison to SRID

Download the Document

Filename
2018 VaxArray Pandemic Influenza Potency Test Assessment and Comparison to SRID.pdf
Size
2 MB
Format
application/pdf

2018 FDA and InDevR VaxArray HA and NA Quantitation Compared with SRID

Download the Document

Filename
2018 FDA and InDevR VaxArray HA and NA Quantitation Compared with SRID.pdf
Size
1 MB
Format
application/pdf

GSK and InDevR VaxArray Replacing SRID with Improved Analytical Testing

Download the Document

Filename
2017 GSK and InDevR VaxArray Replacing SRID with Improved Analytical Testing.pdf
Size
1 MB
Format
application/pdf

 

 

Go Further

IMAGE VAXARRAY Sample - Clipped

VAXARRAY® EXPERT SERVICES

VaxArray® Expert Services’ team provides vaccine manufacturers with tailored workflow solutions to help address development bottlenecks and accelerate analysis and validation.

Webinar - Molecular Innovation for Food Pathogen Testing

Next Generation mRNA Vaccine CQA Analytics

Learn why analytical methods developed for traditional monovalent vaccines are a bottleneck for mRNA vaccine development and how InDevR, manufacturer of VaxArray®, utilizes decades of multiplexed assay development and manufacturing experience to accelerate this process.